GVK Biosciences shortlisted for the European Outsourcing Awards 2009
October 3rd, 2009GVK Biosciences Private Limited (GVK BIO), Asia’s leading research services company has been shortlisted for two European Outsourcing Awards 2009.
GVK BIO had filed its nominations under two categories “Best New Product” and the “Bes t New Partnership/ cquisition/Merger” GVK BIO’s entry for the “Best New Product” was its innovative “Clinical Biomarker Database” developed together with a Big Pharma and the US FDA “. “GVK BIO – Wyeth: Value co-creators” was GVK BIO’s nomination for the “Best New Partnership”.
“We are delighted to know that we have been shortlisted for both our nominations I look forward to winning both the Awards. I take this opportunity to thank all our clients, for their unstinted support and faith in GVK BIO”, said Manni Kantipudi, President, GVK Biosciences.
The European Outsourcing Awards is a gala dinner event to recognize new and significant developments in Contract Services. Launched in 2005, it is designed to reward successful companies for their outstanding contributions throughout the year. This year they will be held at the InterContinental Madrid Hotel, Madrid on the 14 of October, during the week of the CPhI/ICSE/P-MEC.
About GVK BIO:
GVK Biosciences (GVK BIO) is Asia’s leading research services organization. GVK BIO provides a broad spectrum of services, stand-alone and integrated, across the R&D value chain GVK BIO’s diverse portfolio of more than 100 customers includes Big Pharma companies, Agri & Life – sciences companies, leading biotechs and academic institutions. Spread across four locations in India, GVK BIO is headquartered at Hyderabad, India and employs 1500+ people to assist clients accelerate their research and success.
